2012 |
|
January 25 |
FSMA's "One-Forward, One-Back" Tracking System for US Food Supply Explored in The Food and Drug Law Institute's Food and Drug Policy Forum |
January 10 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses Consequences of HHS' Decision To Overrule FDA on Plan B |
January 3 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses Preclearance Process for Class II Devices
|
2011 |
|
December 14 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses Patent Use Codes and the Orange Book |
December 5 |
The Food and Drug Law Institute To Present Distinguished Service and Leadership Awards to Andersen, Autor, Brady, Thirolf |
November 23 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses Impact of FDA's New Dietary Ingredient Guidance Document |
November 9 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses FDA's Potential Use of Biosimilars Naming and Labeling |
October 26 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses Generic Drug Liability in Light of Mensing Decision |
October 12 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses Orange Book's Regulation of "Skinny Labeled" Generic Drugs |
September 27 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses FDA and Innovation |
September 14 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses FDA Regulation of Laboratory-Developed Tests |
August 23 |
The Food and Drug Law Institute's Food and Drug Policy Forum Discusses Drug Shortage Problem in United States |
August 9 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Examines Ethics of Regulating Genetically Engineered Animals
|
July 29 |
FDLI Schedules Dialogue on 510(k) Clearance Following Release of Major IOM Report |
July 26 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Issue Examines Park Doctrine Enforcement |
July 12 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Issue Examines FDA Funding |
June 21 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Issue Examines Financial Disclosure for Clinical Investigators |
June 6 |
The Food and Drug Law Institute's Food and Drug Policy Forum Issue Examines FDA Treatment of Unapproved Versions of Makena |
May 24 |
Food and Drug Law Institute's Food and Drug Policy Forum
Issue Examines Loopholes in Tobacco Regulatory Structure |
May 10 |
Should Congress Pass Legislation to Regulate Child-Directed Food Advertising? |
April 26 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Issue Examines Challenges of the Food Safety Modernization Act |
April 26 |
The Food and Drug Law Institute To Hold Conference on
U.S.-China Food and Drug Law |
April 12 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Seventh Issue Suggests Changes to Clinical Trials |
March 22 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Sixth Issue Discusses FDA's Drug Review Process |
March 9 |
The Food and Drug Law Institute's Food and Drug Policy Forum Fifth Issue Discusses Biosimilar Approval Pathways |
February 22 |
The Food and Drug Law Institute's Food and Drug Policy Forum
Fourth Issue Discusses FDA's Patent Regulations |
February 8
|
New FDLI's Food and Drug Policy Forum Focuses On Liability Issues in Vaccine Design Defect Claims |
January 25
|
FDLI's Food and Drug Policy Forum Examines European GMO Rules |
January 10 |
Elizabeth Anderson, Daniel Shaw Elected to FDLI's Board of Directors:
Minnie Baylor-Henry, Geoffrey Levitt Become Chair, Vice Chair of Board;
Patricia Shrader Named Treasurer
|
2010 |
|
December 15
|
Food and Drug Law Institute To Hold Historic Conference on U.S.-China Food and Drug Law: Top U.S. and Chinese Government Officials Expected to Speak at June 13-14, 2011 Meeting in Beijing |
December 7
|
Food and Drug Law Institute Launches New Policy Publication
First Issue Examines Medical Countermeasures |
November 30 |
FDLI To Honor Beardsley, Landa, Silverglade and Taylor:
Honorees Will Receive Distinguished Service and Leadership Award at Holiday Reception December 7 |
November 1 |
Food and Drug Law Journal E-Advance Discusses Biosimilar Standards |
July 28 |
New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals,
Biologics to Federal Government |
March 12 |
FDA Commissioner Margaret Hamburg To Address FDLI's Annual Conference |
February 8 |
Food and Drug Law Institute Launches First Members Only Resource Center |
2009 |
|
December 9 |
Beers, Dickinson, Levine, Tandy To Receive Food and Drug Law Institute's
Distinguished Service and Leadership Award |
November 6 |
FDLI Names New President and Chief Executive Officer |
July 23 |
FDLI Publishes New FDA Directory with Obama Appointees |
July 17 |
New FDLI Monograph on Federal Price Reporting Requirements Provides Essential
Guidance on Commercial Strategy, Compliance Issues |
June 22 |
FDA's Current Ability to Regulate Genetic Testing Is Problematic,
FDLI-AAAS Colloquium Attendees Say |
May 1 |
FDLI Book Maps out Pharmacovigilance Provisions in More than Dozen Countries |
February 13 |
Anita Goel To Be Featured Luncheon Speaker At FDLI's Annual Nanotechnology Conference |
February 3 |
Risk-Management Policies Needed Now in Nanotechnology, Insighter Piece Concludes;
FDLI Sponsors Nanotechnology Meeting, Publishes Book on FDA-Regulated Products |
January 23 |
Food and Drug Law Institute Announces Writing Award Winners |
January 7 |
Food and Drug Law Institute Sponsors Major Conference on Nanotechnology
Law, Regulation and Policy |
2008 |
|
November 17 |
FDLI Names 2009 Distingished Service and Leadership Award Recipients |
September 17 |
New FDLI Book Provides Comprehensive Guidance on Off-Label Communication |
June 12 |
FDLI, AAAS Host June 20 Conference on Personalized Medicine |
May 29 |
Personalized Medicine: A Challenging Revolution in Healthcare |
May 28 |
FDLI Publishes Comprehensive Handbook on Pharmaceutical Risk Management |
May 5 |
AAAS, FDLI Sponsor Landmark Meeting on Personalized Medicine June 20, 2008 |
February 20 |
FDA Needs To Systematically Collect Vital Nanotech Data, Attorney Says |
January 29 |
EPA Launches Major Nanotechnology Monitoring Project; Top Government Officials
to Speak at FDLI Conference |
January 23 |
FDA Beginning to Address Nanotechnology Regulatory Concern |
January 21 |
Nancy L. Buc Elected Chair of Board of Directors at Food and Drug Law Institute |
January 9 |
51st Food and Drug Law Institute Annual Conference Focuses on Relationship
between Scientific Advances and FDA Law & Regulation |
2007 |
|
December 20 |
Food and Drug Law Institute Sponsors Major Enforcement Conference |
December 18 |
Clinical Trial Participation Unaffected by Disclosure of Investigator's Financial Stake
Food and Drug Law Journal Article Finds |
December 14 |
Food and Drug Law Institute Sponsors Major Food Safety Conference
|
December 10 |
Food and Drug Law Institute, Project on Emerging Nanotechnologies Co-Sponsor
Major Conference on Nanotechnology Law, Regulation and Policy |
November 26 |
Updated Press Release Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information |
October 17 |
Food and Drug Law Institute Sponsors Colloquium on Communicating
Risk/Safety Drug Information |
June 28 |
System for Gaining Access to Unapproved Drugs Flawed, Conclude Expert Panelists
at FDLI's Colloquium Series #2 |
May 30 |
Food And Drug Law Institute Sponsors National Colloquium On Rights, Responsibilities And Other Issues Related To The Provision Of Unapproved Drugs |
May 1 |
FDLI 50th Annual Meeting Heralds New Era in Healthcare Innovations, FDA Regulations |
March 1 |
FDLI Publishes White Paper on Access to Unapproved Drugs |
February 22 |
FDLI's Feb 27 Colloquium On Access to Unapproved Drugs Takes Place Two Days Before Landmark Court Hearing |
January 22 |
FDA Primed to Help Dying Patients Gain Easier Access to Unapproved Drugs |
2006 |
|
November 28 |
Food And Drug Law Institute Sponsors National Colloquium On Access
To Unapproved Drugs |
August 14 |
James J. Kelly Selected New President and CEO at FDLI |
